巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Illumina

ILMN
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Illumina - 延遲價格・最後更新於 26/01 12:15
最高位
348.490
最低位
327.210
開市價
--
前收市價
345.090
成交量(千)
66.04
成交額(百萬)
176.37
買入
--
賣出
--
每手股數
--
市值(百萬)
51,857.21
市盈率
54.300
息率
--
差價
--
52週高低
555.770 - 327.120
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Illumina
證券代碼
ILMN.US
所屬板塊
Diagnostics & Research
公司業務
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
發行量
146000000
公司總部
200 Illumina Way
公司網址
https://www.illumina.com
公司電郵
ir@illumina.com
公司電話
+1 858 202-4500

Illumina預計第四季度營收約為11.9億美元

格隆匯·
Illumina預計第四季度營收約為11.9億美元

ARK追蹤|不管漲跌 儘管甩賣特斯拉 京東也被賣了

辛海棠·
ARK追蹤|不管漲跌 儘管甩賣特斯拉 京東也被賣了

關於

Illumina(ILMN.US)所屬的行業板塊為Diagnostics & Research。
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
詳細公司背景可參考: https://www.illumina.com